PPARG and type 2 diabetes mellitus: The thiazolidinedione derivative known as Pioglitazone is a peroxisome proliferator-activated receptor gamma (PPAR-γ) agonist developed by the Takeda pharmaceutical company and approved by FDA in 1999 for management of type 2 diabetes.